Goal | To reduce transfusion-transmitted HIV infection. | ||
Objective |
Ensure supply and safety of the national blood supply. |
||
Action
Steps
|
|
||
Descriptions
|
Encourage high risk donors to exclude themselves; update list of unsuitable donors; quarantine and test blood; investigate incidents to identify, and rectify common errors in blood banks. |
||
Resources
|
FY95
|
FY96
|
FY96
|
$
17.5 million
|
$
17.5 million
|
$
17.5 million
|
|
Populations
Served |
All persons who may receive blood or blood products. |
||
Constituency
Involvement |
The FDA depends on scientific advisory committees to provide independent expert advice to the agency in its evaluation of regulated products. These committees are composed of representatives from academia, research, government, industry, and patient advocates. |
CDCC #1- Appendix A: Prevention
FDA
President and First Lady | Vice President and Mrs. Gore
Record of Progress | The Briefing Room
Gateway to Government | Contacting the White House | White House for Kids
White House History | White House Tours | Help
Privacy Statement